Curie Therapeutics Inc.
2F Gill Street
Woburn MA 01801
For Media:
sarah@argotpartners.com
For Investors:
kevin@argotpartners.com
CAMBRIDGE, Mass., March 14th, 2022 — Curie Therapeutics Inc. (“Curie”), a biotechnology company focused on developing innovative radiopharmaceutical therapies for oncological diseases, today announced the appointment of Georgette Verdin as the Company’s Chief People Officer. “Our people are central to achieving our vision of transforming the use of radiopharmaceuticals in oncology. We are invested in…
Curie Therapeutics Inc.
2F Gill Street
Woburn MA 01801
For Media:
sarah@argotpartners.com
For Investors:
kevin@argotpartners.com